Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial

Authors

Pascal Lebray (ORCID: https://orcid.org/0000-0001-8719-6533)
Stéphanie Faure (ORCID: https://orcid.org/0000-0002-8544-1272)
P. Cacoub (ORCID: https://orcid.org/0000-0002-6727-4992)
Marion Migueres (ORCID: https://orcid.org/0000-0001-7791-3201)
Jean‐François Viallard (ORCID: https://orcid.org/0000-0001-7500-9323)
Laurent Alric (ORCID: https://orcid.org/0000-0003-0676-7539)
L. Sailler (ORCID: https://orcid.org/0000-0003-3482-6903)
Clara Brusq (ORCID: https://orcid.org/0000-0002-7172-2807)
Dominique Chauveau
G. Pugnet
Emilie Bérard

Institutions

Université Toulouse III - Paul Sabatier (FR)
Université de Bordeaux (FR)
Université de Montpellier (FR)
Centre Hospitalier Universitaire de Toulouse (FR)
Sorbonne Université (FR)
Centre Hospitalier Universitaire de Montpellier (FR)
Toulouse Mathematics Institute (FR)
Department of Virology (FR)
Pitié-Salpêtrière Hospital (FR)
Hôpital Purpan (FR)

Publication Details

Journal: Lupus Science & Medicine
Published: 2025-03-01
DOI: https://doi.org/10.1136/lupus-2024-001435
Citations: 1
Primary Topic: COVID-19 Clinical Research Studies
Type: article
Field-Weighted Citation Impact: 1.40

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial

Pascal Lebray, Stéphanie Faure, P. Cacoub, Marion Migueres et al.

Mar 1, 2025

1 citations

Lupus Science & Medicine

COVID-19 Clinical Research Studies

1.40

article

Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial

Pascal Lebray, Stéphanie Faure, P. Cacoub, Marion Migueres, Jean‐François Viallard, Laurent Alric, L. Sailler, Clara Brusq, Dominique Chauveau, G. Pugnet, Emilie Bérard

March 1, 2025article en

1 citations

Abstract

No abstract available for this paper.

Lupus Science & MedicineVol. 12(1)

Université Toulouse III - Paul Sabatier (FR), Université de Bordeaux (FR), Université de Montpellier (FR), Centre Hospitalier Universitaire de Toulouse (FR), Sorbonne Université (FR), Centre Hospitalier Universitaire de Montpellier (FR), Toulouse Mathematics Institute (FR), Department of Virology (FR), Pitié-Salpêtrière Hospital (FR), Hôpital Purpan (FR)

Good health and well-being

Openalex Percentile: Top 23%

COVID-19 Clinical Research Studies

1.40

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren’s disease: Prepcov multicentre trial — Pascal Lebray, Stéphanie Faure, et al. · Lupus Science & Medicine (2025) | TGRS Research Map | TGRS